CTLT | Catalent, Inc. |
Pharmaceutical Preparations |
Book value per $ invested | nan |
Leverage | nan% |
Market Cap | $ 10.9B |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -339.9m |
Margin | -8.31% |
Catalent, Inc. (Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products.